Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Malaysia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20101
20121
20181
20201
20213
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
AstraZeneca2
Celcuity Inc1
Checkpoint Therapeutics, Inc.1
Incyte Corporation1
International Breast Cancer Research Foundation1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
R-Pharm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis12
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung3
Neoplasms2
Anemia1
Blood Protein Disorders1
Bone Diseases1
Bone Marrow Diseases1
Bone Neoplasms1
Breast Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.